GSK adds to its commitment to GAVI Alliance to help protect millions more children against infectious diseases

New extension of Synflorix vaccine supply agreement will help protect an additional 80 million children in the world’s poorest countries from pneumococcal disease.
Source: GSK news - Category: Pharmaceuticals Source Type: news